跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.171) 您好!臺灣時間:2026/04/10 02:01
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:陳弘明
研究生(外文):Chen, Hung Ming
論文名稱:天麻萃取物之抗氧化活性與細胞保護效用
論文名稱(外文):Antioxidative Activity and Cell Protective Effect of Gastrodia elata Blume
指導教授:凃瑞澤凃瑞澤引用關係吳淑姿吳淑姿引用關係
指導教授(外文):Too, Jui RzeWu, Shwu Tzy
口試委員:凃瑞澤翁義銘鄭啟清吳芳禎
口試委員(外文):Too, Jui RzeWeng, Yih MingJeng, . Kee ChingWu, Fang Chen
口試日期:2011-06-17
學位類別:碩士
校院名稱:大葉大學
系所名稱:生物產業科技學系
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2011
畢業學年度:99
語文別:中文
論文頁數:73
中文關鍵詞:天麻天麻素清除自由基能力TBARS
外文關鍵詞:Gastrodia elatagastrodinfree radical scavenging capacityTBARS
相關次數:
  • 被引用被引用:1
  • 點閱點閱:1443
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
天麻中主要有效成分為天麻素(gastrodin)與其代謝物天麻苷元(p-Hydroxybenzyl alcohol, 4-HBA),兩者均具有特殊生理活性。已有研究發現,天麻素具有抗癲癇、治療肢麻癱瘓、鎮靜、抗驚厥、抗炎、鎮痛、抗衰老及改善記憶學習等功效。氧化壓力會產生自由基,進而引起蛋白質、醣類及脂肪等成分進行連鎖反應,而破壞體內的細胞膜、蛋白質及核酸等,人體許多功能逐漸破壞,造成老化、癌症、動脈粥樣硬化(atherosclerosis)、發炎反應和免疫問題等疾病。本研究使用中藥天麻,利用不同溶劑(去離子水、甲醇或70%乙醇)之熱回流萃取天麻成分,測定萃取率、抗氧化活性試驗及細胞生存能力之測定。抗氧化活性測試包含α,α-diphenyl-β-picryl -hydrazyl (DPPH)自由基清除能力、還原力試驗和相對還原力、超氧歧化酶(superoxide dismutase) 活性、ABTS陽離子自由基清除活性及抑制硫代巴比妥酸鹽反應產物(thiobarbituric acid reactive substances, TBARS)生成之活性,並測定抗氧化物質總酚含量。結果顯示,天麻不同溶劑萃取率分別為:去離子水萃取物40.9%、甲醇萃取物20.6% 和乙醇萃取物9.77%;總酚含量之測定以甲醇萃取物最高,達6.48 mg/g;DPPH自由基清除能力以甲醇萃取物最佳,在濃度0.4 mg/mL時達到97.3%;在還原力測定中,去離子水萃取物有最高還原力,其相對還原力在0.8 mg/mL達23.3%;超氧歧化酶活性測定中,乙醇萃取物有最高活性,在濃度1 mg/mL時達到44.9%;ABTS陽離子自由基清除活性中,乙醇萃取物有最高活性,在濃度0.1 mg/mL時達到26.8%;抑制硫代巴比妥酸鹽反應產物之活性測定,乙醇萃取物具有最高活性,在濃度1 mg/mL時達到93.4%。以缺氧再灌氧模式對PC-12細胞株存活度測定中,70%乙醇萃取物有最高保護性,在濃度100μg/mL時達到81.3%; 以過氧化氫模式對PC-12細胞株存活度測定中,標準品4-HBA 之細胞保護活性較高,在濃度50 μg/mL 時約達97.1%; 熱迴流法之70%乙醇萃取物較差,其最佳保護活性在濃度50 μg/mL 時,細胞存活度仍達94.3%。
Gastrodin and p-hydroxybenzyl alcohol (4-HBA) are the main active constituents of Gastrodia elata of which has numerous physiological functons, and has been used as an anti- convulsant, analgesic and sedative agent for the therapeutics of epilepsy, paralysis, inflammation, aging, and ameliorated memory impairment. The oxidative stress is caused by free radicals that increase the chain reactions of proteins, polysaccharides and lipids. The results are altered cellular oxidation and impaired cellular function in many neurodegenerative diseases including aging, cancer, atherosclerosis, inflammation and immune problems. In ths study, extracts of Tianma (G. elata), extracted with a variey of solvents via diferrent extraction, were applied to the cell viability and the measurement of the yield, total phenol content and the in vitro antioxidant activity, including the free radical scavenging activity of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ABTS cation, reducing power assay, superoxide dismutase activity and the inhibition activity of thiobarbituric reactive substances (TBARS); the PC-12 cell line was established to evaluate the protective function of G. elata extracts. As a result, the water extract obtained via hot reflux has the highest yield of 40.9%. For the antioxidant activity evaluation, the methanolic extract of G. elata has the highest DPPH scavenging activity (97.3%) at a concentrationf 0.4 mg/mL and the ethanolic extract of G. elata has the highest inhibition capacity of TBARS (93.4%) at a concentration of 1.0 mg/mL. The result of PC-12 cell viability in hypoxia-reoxygenation model suggested that the ethanolic extract of G. elata has the highest protective effect (about 81.3%) at a concentra-tion of 100 μg/mL. In the protective activity result of H2O2-induced cell death model, the highest protective activity (about 97.1%) standard 4-HBA had and followed the 70% ethanolic extract of G. elata (about 94.3%) at a concentration of 50 μg/mL.
目錄
封面內頁
簽名頁
中文摘要…………………………………………………iii
英文摘要…………………………………………………v
致謝………………………………………………………vii
目錄………………………………………………………viii
圖目錄……………………………………………………xiii
表目錄……………………………………………………xiv
1. 緒論……………………………………………………‥1
2. 文獻回顧………………………………………………‥2
2.1 天麻簡介 ……………………………………………‥2
2.2 天麻分類 ……………………………………………‥2
2.2.1天麻特徵……………………………………………‥2
2.2.2天麻的營養方式……………………………………‥3
2.2.3天麻之藥物使用與安全性…………………………‥3
2.3天麻目前研究…………………………………………‥7
2.3.1 天麻萃取物抑制多巴胺系統相關疾病機轉 ……‥7
2.3.2 天麻萃取物抑制GABA系統相關疾病機轉………‥8
2.3.3 天麻萃取物抑制一氧化氮合成酶(NOS)機轉…‥14
2.3.4 天麻萃取物調控乙二醛酶解毒系統機制………‥15
2.4 自由基……………………………………………‥‥19
2.4.1 自由基簡介……………………………………‥‥19
2.4.2 自由基之產生…………………………………‥‥19
2.5 抗氧化機制…………………………………‥‥‥‥23
2.5.1 抗氧化劑………………………………………‥‥23
2.5.2 抗促氧化反應之原理………………………………24
2.5.3 過氧化氫誘發細胞損傷………………………‥‥25
2.6 實驗目的…………………………………………‥‥26
3. 材料與方法……………………………………………‥27
3.1 實驗材料 ……………………………………………‥27
3.1.1 天麻萃取物製備……………………………………27
3.1.2培養PC-12細胞株…………………………………‥27
3.2 試驗材料……………………………………………‥ 27
3.2.1 試驗溶劑…………………………………………‥27
3.2.2 試驗藥品……………………………………………28
3.2.3 PC-12細胞株之培養基組成……………………‥29
3.2.4 PC-12細胞株之培養方法………………………‥30
3.3 試驗設備……………………………………………‥30
3.4 實驗架構……………………………………………‥31
3.5 天麻之抗氧化試驗…………………………………‥33
3.5.1 天麻苷元含量分析………………………………‥33
3.5.2抗氧化成分分析…………………………………‥ 33
3.5.2.1 總酚化合物含量分析…………………………‥33
3.5.2.2 類黃酮含量測定………………………………‥34
3.5.3抗氧化活性測試…………………………………‥ 36
3.5.3.1還原力測試……………………………………‥ 36
3.5.3.2清除超氧陰離子活性試驗……………………‥ 36
3.5.3.3清除α,α-Diphenyl-β-picrylhydrazyl(DPPH) 自由基之測定…………‥37
3.5.3.4螯合亞鐵離子之測定……………………………………………………………‥ 37
3.5.3.5硫代巴比妥酸鹽反應產物 (TBARS)之測定………………………………………37
3.5.3.6清除ABTS陽離子自由基能力………………………………………………………38
3.5.4細胞存活度(Cell viability)試驗……………………………………………… 39
4. 結果與討論……………………………………………………………………………… 41
4.1 天麻萃取率………………………………………………………………………………41
4.2 天麻苷元含量測定………………………………………………………………………41
4.3 抗氧化成分含量分析……………………………………………………………………42
4.3.1 總酚化合物含量測定…………………………………………………………………42
4.3.2 類黃酮含量測定………………………………………………………………………42
4.4 抗氧化活性測試…………………………………………………………………………45
4.4.1 還原力測試…………………………………………………………………………‥45
4.4.2 螯合亞鐵離子之測定………………………………………………………………‥45
4.4.3 清除α,α-Diphenyl-β-picrylhydrazyl(DPPH) 自由基之測定…………‥ 47
4.4.4 清除超氧陰離子活性測試…………………………………………………………‥50
4.4.5 硫代巴比妥酸鹽反應產物 (TBARS)之測定…………………………………………52
4.4.6 清除ABTS陽離子自由基能力…………………………………………………………54
4.5細胞存活度(Cell viability)試驗……………………………………………………57
4.5.1缺氧再灌氧模式…………………………………………………………………………57
4.5.2過氧化氫模式……………………………………………………………………………57
5. 結論…………………………………………………………………………………………62
5.1結論…………………………………………………………………………………………62
5.2展望…………………………………………………………………………………………63
參考文獻…………………………………………………………………………………………64
附錄………………………………………………………………………………………………73
圖目錄
圖2.1 a 天麻植株…………………………………………………………………………………5
圖2.1 b 天麻乾燥塊莖……………………………………………………………………………6
圖2.2 a 天麻主要活性成分之化學結構式………………………………………………………12
圖2.2 b GABA與其代謝物之交互作用……………………………………………………………13
圖2.3 動物體內乙二醛類化合物代謝途徑………………………………………………………18
圖2.4 a自由基連鎖反應簡式………………………………………………………………………21
圖2.4 b脂肪酸之自由基連鎖反應…………………………………………………………………21
圖 3.1 實驗架構……………………………………………………………………………………32
圖 3.2 類黃酮之分類………………………………………………………………………………35
圖 4.1 天麻萃取物之相對還原力…………………………………………………………………46
圖 4.2 天麻萃取物之清除DPPH自由基能力………………………………………………………49
圖 4.3 天麻萃取物之清除超氧陰離子活性………………………………………………………51
圖 4.4 天麻萃取物之抑制TBARS活性……………………………………………………………53
圖 4.5 天麻萃取物之清除ABTS活性………………………………………………………………56
圖 4.6 天麻萃取物對細胞生存能力之測定(缺氧再灌氧模式)....................59
圖 4.7 天麻萃取物對細胞生存能力之測定(過氧化氫模式)......................60
表目錄
表 1. 天麻萃取物之產率、總類黃酮及總酚含量表..........................43
表 2. 天麻苷元含量.................................................44
1. 行政院衛生署出版國人膳食營養素參考攝取量及其說明, 修訂第六版
2. 周樹南。2001。食品添加劑的危險評估與發展。江蘇衛生保健。3(3): 6–7
3. Abordo, E.A., Minhas, H.S., and Thornalley, P.J. 1999. Accumulation of alpha-oxaldehyde during oxidative stress, role in toxicity. Biochem. Pharmacol. 58: 641–648
4. Akabas, M.H. (2004) Na+/ Ca2+ exchange inhibitor: potential drugs to mitigate the severity of ischemic injury. Mol. Pharmacol. 66: 8–10
5. Ahn, E.K., Jeon, H.J., Lim, E.J., Jung, H.J., and Park, E.H. 2007. Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume. J Ethnopharmacol. 110: 476–482
6. Aiorgan,J.E., Honess, D.J., and Bleehen, N.M. 1979. The interaction of thermal tolerance wit drug cytotoxicity in vitro. Br. J. Cancer. 39: 422–428
7. Aktan, F. 2004. Minireview: iNOS-mediated nitric oxide production and its regulation. Life Science. 75: 639–653
8. Alberto, J.E., and Henderson, K.K. 2011. Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection. Neurology. 76: 1529–1531
9. Amicarelli, F., Colafarina, S., and Cattani, F. 2003. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic. Biol. Med. 35: 856–871
10. An, S.J., Park, S.K., Hwang, I.K., Choi, S.Y., Kim, S.K., Kwon, O.S., Jung, S.J., Baek, N.I., Lee, H.Y., Won, M.H., and Kang, T.C. 2003. Gastrodin decreases immunoreactivities of gamma-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils. J Neurosci. Res. 71(4): 534–43
11. Barboni, B., Mattioli, M., Gioia,L., Turriani, M., Capacchietti, G., and Lucidi. P. 2003. Apoptosis in Cooled Porcine Oocytes: Role of Calcium (Ca2+) and Ca2+-dependent Enzymes. Veterinary Research Communications. 27(1): 203–206
12. Belardo, G., Piva, R., and Santoro, M.G. 2010. Heat stress triggers apoptosis by impairing NF-κB survival signaling in malignant B cellsHeat shock impairs NF-κB survival signaling. Leukemia. 24: 187–196
13. Bray, H.G., and Thorpe, W.V. (1954) Meth. Biochem. Anal. 1: 27-52.
14. Bartyik, K., Turi, S., Orosz F., and Karg, E. 2004. Methotrexate inhibits the glyoxalase system in vivo in children with acute lymphoid leukaemia. Eur. J. Cancer. 40 (15): 2287–2292
15. Bensky, D. and Gramble, A. 1993. Chinese Herbal Medicine: Material Medica. pp:971–974. Rev. Edition. Eastland Press, Seattle.
16. Centonze, D., Gubellini, P., Usiello, A., Rossi, S., Tscherter, A., Bracci, E., Erbs, E., Tognazzi, N., Bernardi, G., and Pisani, A. 2004. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience. 129: 157–166
17. Cereghino, J. J. and Penry,J.K. 1995. Introduction. In: R.H. Levy, R.G. Mattson and B.S. Meldrum, Editors, Antiepileptic drugs IV, pp. 1–11. Raven Press, New York.
18. Chang, H.C., and Branen, A.L. 1975. Antimicrobial effect of butylated hydroxyanisole (BHA) [Food product, antioxidant]. J. Food. Sci. 40: 349–351
19. Chang, H.Y., Ho, Y.L., Sheu, M.J., Lin, Y.H., Tseng, M.C., Wu, S.H., Huang, G.J., and Chang, Y.S. 2007. Antioxidant and free radical scavenging activities of Phellinus merrillii extracts. Botanical Studies. 48: 407–417
20. Choudhary, D., Chandra, D., and Kale, R. K. 1997. Influence of methylglyoxal on antioxidant enzyme and oxidative damage. Toxicol. Lett. 93: 141–152
21. Deng Y, Chen, X, and Ye Y. 1997. Effects of glycated protein on the expression of plasminogen activator inhibitor-1 of cultured human mesangial cells. Zhonghua Yi Xue Za Zhi. 77: 672–675
22. Duilio, C., Ambrosio, G., Kuppusamy, P., DiPuala, A., Becker, L.C., and Zweier J.L. 2001. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol. 280: H2649–2657
23. Emillien, G., Maloteaux, J.M., Geurts, M., Hoogenberg, K., and Cragg, S. 1999. Dopamine receptors-physiological understanding to therapeutic intervention potential. Pharmacology & Therapeutics. 84: 133–156
24. Filomeni, G., Rotilio,G. and Ciriolo, M.R. 2005. Disulfide relays and phosphorylative cascades: partners in redox- mediated signaling pathways. Cell Death and Differentiation. 12: 1555–1563
25. Finkel,T. and Holbrook, N.J. 2000. Oxidants, oxidative stress and the biology of ageing. Nature. 408: 239–247
26. Frangogiannis, N.G., Smith, C.W., and Entman, M.L. 2002. The inflammatory response in myocardial infarction. Cardiovasc Res. 53: 31–47
27. Gale, C.P., Futers, T.S., and Summers, L.K. 2004. Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors. Diab Vasc Dis Res. 1(1):34–39
28. Gangadhariah, M.H., Mailankot, M., Reneker, L., and Nagaraj, R.H. 2010. Inhibition of methyl- glyoxal-mediated protein modification in glyoxalase Ⅰoverexpressing mouse lenses. J Ophthalmol. pp: 274–317
29. Geller, D.A., de Vera, M.E., Russell, D.A., Shapiro, R.A., Nussler, A.K., Simmons, R.L., and Billar, T.R. 1995. A central role of IL1 beta in the in vitro smf in vivo regulation of hepatic inducible nitric oxide synthase, IL-1b induces hepatic nitric oxide synthsis. Journal of Immunology. 155: 4890–4898
30. Greene, L.A., Aletta, J.M., Rukenstein, A., and Green, S.H. 1987. PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Methods Enzymol. 147: 207-216
31. Grimaldi, B.L. 2002. The central role of magnesium deficiency in Tourette’s syndrome: causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette’s syndrome and several reported comorbid conditions. Medical Hypotheses. 58: 47–60
32. Gross, M. 2004. Flavonoids and Cardiovascular Disease. Pharmaceutical Biology. 42(S1) : 21–35
33. Guo, Z., Tan, T., Zhong, Y., and Wu, C. 1991. Study of the mechanism of gastrodin and derivatives of gastrodigenin. Hua Xi Yi Ke Da Xue Xue Bao (華西醫科大學學報). 22(1): 79–82
34. Guo, Z., Tan, T., Zhong, Y., and Wu, C. 1992. Screening of gastrodigenin derivatives as ligands for neuroreceptor imaging. Zhonghua Heyixue Zazhi (中華核醫學雜誌). 12(1): 11–13
35. Guo, Z., Tan, T., Liang, Z., Kuang, A., Wu, C., and Zhong, Y. 1993. A sensitive BZ receptor binding assay and its application to the study of interaction between gastrodigenin derivatives and BZ receptor. Zhonghua Heyixue Zazhi. 13(1): 31–33
36. Ha, J.H., Lee, D.U., Lee, J.T., Kim, J.S., Yong C.S., Kim, J.A., Ha, J.S., Huh, K. 2000. 4-Hydroxy- benzaldehyde from Gastrodia elata Bl. is active in the antioxidation and GABAergic neuromodulation of rat brain. J Ethnopharmacology. 73: 329–333
37. Ha, J.H., Shin, S.M., Lee, S.K., Kim, J.S., Shin, U.S., Huh, K., Kim, J.A., Yong C.S., Lee, N.J., and Lee, D.U. 2001. In vivo effects of hydroxybenzaldehyde from Gastrodia elata and their analogs on GABAergic neurotransmission, and a structure-activity correlation. Plant Medica. 67: 877–880
38. Halliwell, B., Gutteridge, J.M.C., and Aruoma, O.I. 1987. The deoxyribose method: A simple ‘‘test−tube’’ assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem. 165: 215–219
39. Halliwell, B. 2008. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys. 7:7
40. Harman, D. 1992. Role of free radicals in aging and disease. Annals of New York Academy of Sciences. 673:126–141
41. Hipkiss, A. R., Brownson, C, and Carrier., M. J. 2001. Carnocine, the antiaging, antioxidant dipeptide may react with protein carbonyl group. Mech. Age and Develop. 122: 1431–1445
42. Hirai, S., Tanaka, M. and Sotomatsu, A. (1990) Free radicals and degenerative diseases of the nervous system. Nippon Ronen Igakkai Zasshi. 27 (2): 171–176
43. Hollman, P.C.H., van Trijp, J.M.P., and Buysman, M.N.C.P. 1996. Fluorescence detection of flavonols in HPLC by postcolumn chelation with Aluminum. Anal. Chem. 68 (19): 3511–3515
44. Hsieh, C.L., Chen, C.L., Tang, N.Y., Chuang, C.M., Hsieh, C.T., Chiang, S.Y., Lin, J.G., Hsu, S.F. 2005. Gastrodia elata BL mediates the suppression of nNOS and microglia activation to protect against neuronal damage in kainic acid-treated rats. AJCM. 33: 599–611
45. Huang, Y., Song L., Wu, S., Fan, F., and Lopes-Virella M.F. 2001. Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells. Atherosclerosis. 156: 119–125
46. Huang, Z. B., W, Z., Chen, F. K. and Zou, L. B. 2006. The Protective effects of phenolic constituents from Gastrodia elata on the cytotoxicity induced by KCl and Glutamate. Arch Pharm Res. 29(11): 963–968
47. Jacobs, A. and Miles, P. M. 1969. Role of gastric secretion in iron absorption. Gut. 10: 226–229
48. Karasu, C. 2010. Glycoxidative stress and cardio- vascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J. 26 (4): 240–256
49. Kim, D. K., Cho,E.S., Seong, J. K., and Um, H.D. 2001. Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J. Cell Sci. 114(23): 4329-4333
50. Lefer, D.J. and Granger, D.N. 2000. Oxidative stress and cardiac disease. Am J Med. 109:315-323
51. Li, Y., Song,Y.H., Diez, J.G., Elaydar, MacA. A., Wu, H.J., and Geng, Y.J. 2009. High glucose induces apoptosis in endothelial cells via epigenetic regulation of insulin-like growth factor receptor expression. Circulation. 120: S1141
52. Lin, L. C., Chen, Y. F., Lee, W.C., Wu, Y. T. and Tsai, T. H. 2008. Pharmacokinetics of gastrodin and its metabolite p-hydroxybenzyl alcohol in rat blood, brain and bile by microdialysis coupled to LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 48: 909–917
53. Liu, J. and Mori, A. 1992. Antioxidant and free radical scavenging activities of Gastrodia elata Bl. and Unicaria rhynchophylla (MIQ) Jacks. Neuropharma-cology. 31: 1287–1298
54. Liu, X.M., Wang Y.W., Li, D., Ju, X.L. 2008. Transplantation of rat neuronal stem cells reduces stereotypic behaviors. Behavioural Brain Research. 186: 84–90
55. Lo T.W.C., Westwood, M.E. McLellan, A.C., Selwood, T. and Thonalley, P.J. 1994. Binging and modification of proteins by methylgyoxal under phsiological conditions. A kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine, Nα-acetyl-lysine, and bovine serum albumin. J. Biol. Chem. 269: 32299–32305
56. Lowry, O.H. Rosebrough, N.J. Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
57. Lv, H., Li, A.Y., Ma, H.B., Liu, F.Y., Xu, H.L. 2009. Effects of Ningdong granule on the dopamine system of Tourette’s syndrome rat models. J Ethno- pharmacology. 124: 488–492
58. Ma, Q., Kim, E.Y., and Han, O. 2010. Bioactive Dietary Polyphenols Decrease Heme Iron Absorption by Decreasing Basolateral Iron Release in Human Intestinal Caco-2 Cells. J. Nutr. 140(6): 1117–1121
59. McCabe, M.J.Jr., Eckles, K.G., Langdon, M., Clarkson, T.W., Whitekus, M.J., and Rosenspire, A.J. 2005. Attenuation of CD95-induced apoptosis by inorganic mercury: caspase-3 is not a direct target of low levels of Hg2+. Toxicol. Lett.155(1): 161–170
60. Malesev, D. and Kuntic, V. 2007. REVIEW: Investigation of metal–flavonoid chelates and the determination of flavonoids via metal–flavonoid complexing reactions. Rev. J. Serb. Chem. Soc. 72 (10): 921–939
61. Matsukuma, S., Suda, K., Tsukahara, M., and Ishihara, S. 1996. Pancreatic ischaemic lesions without fat necrosis associated with disseminated intravascular coagulation. Virchows Archiv. 429(1): 55–58
62. Muramatsu, H., Kogawa, K., Tanaka M., Okumura, K., Koike, K., and Kuga T. 1995. Superoxide dismutase in SAS human tongue carcinoma cell line is a factor defining invasiveness and cell motility. Cancer Research. 55: 6210–6241
63. Ojemann, L.M., Nelson, W.L., Shin, D.S., Rowe, A.O., Buchanan, R.A. 2006. Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilep. Behav. 8: 376–383
64. Pettmann, B., Henderson, C.E. 1998. Neuronal cell death. Neuron. 20, 633–647
65. Pierce, G.N. and Czubryt, M.P. 1995. The contribution of ionic imbalance to ischenia- reperfusion-induced cell injury. J Mol Cell Cardiol. 27: 53–63
66. Rubens, F.V., de Souza, Sussuchi, E.M., and De Giovani, W.F. 2003. Synthesis, Electrochemical, Spectral, and Antioxidative Properties of Complexes of Flavonoids with Metal Ions. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry. 33(7): 1125–1144
67. Singh, S., Dwarakanath, B.S., and Mathew, T.L. 2004. DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines. Journal of Photochemistry and Photobiology B: Biology. 77(1-3): 45–54
68. Spinella, M. 2001. Herbal medicines and epilepsy:the potential for benefit and adverse effects. Epilepsy Behav. 2: 524–532
69. Swinnen, L.J., Fisher, S.G., and Erickson, L.C. 1989. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II). Carcinogenesis. 10(8): 1465–1470
70. Szocs, K. 2004. Endothelium dysfuction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Phsiol Biophys. 23: 265–295
71. Tang, W., and Eisenbrand, G. 1992. Gastrodia elata Bl. Chinese drugs of plant origin, 71: 545–548. Springer-Verlag, Berlin, Heidelberg.
72. Thornalley, P.J. 1996. Pharmacology of methyl- glyoxal: formation, modification of proteins and nucleic acids, and enzymetic detoxification- a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 27: 565–573
73. Thornalley, P.J. 1998. Glutathione dependent detoxification of α-oxoaldehydes by the glyoxalase system: involvement of disease mechanisms and anti- proliferative activities of glyoxalase Ⅰ inhibitors. Chem. Biol. Interact. 111-112: 137–151
74. Vaca, C.E, Fang, J.L., Conradi, M. and Hou, S.M. 1994. Developemnt of a 32P-postlebelling method for the analysis of 2’-deoxyguanosine- 3’-monophosphate and DNA adducts of methylglyoxal. Carsinogenesis. 15: 1887-1894
75. Vickers, T., After, Y.I.S., and McEneny, J. 2001. "Lipoprotein oxidation and atherosclerosis". Biochem Soc Trans 29(Pt 2): 358–62. PMID 11356183
76. Wang. S., Chen, F., Zhang, Z., Jiang, B.H., Jia, L., and Shi, X. 2004. NF-kappaB prevents cells from undergoing Cr(VI)- induced apoptosis. Mol. Cell Biochem. 255(1-2): 129–137
77. Wang, Y., Chen, D., Wang, D., Huang, Q., Yao, Z., Liu, F., Wei, X., Li, R., Zhang, Z., and Sunday, Y. 2004. Over-expression of Gust radio anti-fungalprotein enhances I erticillium wilt resistance incoloured cotton. Plant Breed. 123:454-459
78. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284: 555–556
79. Yao, M.Z., Nguyen, T.V.V. and Pike, C.J. 2005. Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J. Neurosci. 25(5): 1149–1158
80. Yu, S.J., Kim, J.R., Lee, C.K., Han, J.E., Lee, J.H., Kim, H.S., Hong, J.H., Kang S.G. 2005. Gastrodia elata Blume and an active p–hydroxybenzyl alcohol reduce focal ischemia brain injury through antioxidant related gene expressions. Biochemical and Pharmaceutical Bulletin. 28: 1016–1020
81. Zhao, Y., Cao, Q.E., Xiang, Y., and Hu, Z. 1999. Identification and determination of active components in Gastrodia elata Bl. by capillary electrophoresis. J Chromatogr A, 849: 277–283
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
1. 高俊雄 (1996c)。運動員休閒參與、休閒利益與自覺訓練效果之比較研究。戶外遊憩研究,12(3),43-61。
2. 周佳慧 (2001)。休閒活動與休閒阻礙。中華體育。15(3),144-149。
3. 高俊雄 (1996c)。運動員休閒參與、休閒利益與自覺訓練效果之比較研究。戶外遊憩研究,12(3),43-61。
4. 高俊雄 (1996b)。休閒概念面面觀。國立體育學院論叢,6(1),69-78。
5. 高俊雄 (1996b)。休閒概念面面觀。國立體育學院論叢,6(1),69-78。
6. 高俊雄 (1995)。休閒利益三因素模式。戶外遊憩研究。8(1),15-28。
7. 高俊雄 (1995)。休閒利益三因素模式。戶外遊憩研究。8(1),15-28。
8. 翁萃芳 (2002a)。台灣地區警察人員休閒活動參與及相關因素之分析。中央警察大學警學叢刊,33(3),25-60。
9. 翁萃芳 (2002a)。台灣地區警察人員休閒活動參與及相關因素之分析。中央警察大學警學叢刊,33(3),25-60。
10. 林素麗 (1977)。休閒的理論與研究。思與言雙月刊。15(1),27-35。
11. 林素麗 (1977)。休閒的理論與研究。思與言雙月刊。15(1),27-35。
12. 林月桂 (1991)。台北市立醫療院所護理人員工作滿意度之研究。公共衛生。18(3),262-273。
13. 林月桂 (1991)。台北市立醫療院所護理人員工作滿意度之研究。公共衛生。18(3),262-273。
14. 林一真 (1995)。休閒輔導模式與休閒輔導實務。學生輔導通訊。39,24-31。
15. 林一真 (1995)。休閒輔導模式與休閒輔導實務。學生輔導通訊。39,24-31。